Droplet Health Limited 12144076 true 2025-04-01 2026-03-31 2026-03-31 The principal activity of the company is dormant company Digita Accounts Production Advanced 6.30.9574.0 true Mr Terence Anthony Bloom Mrs Sarah Doerfler Mrs Maureen Lucille Bloom Mr Alexander Simon Bloom false false 12144076 2025-04-01 2026-03-31 12144076 2026-03-31 12144076 bus:OrdinaryShareClass1 2026-03-31 12144076 core:ShareCapital 2026-03-31 12144076 core:SharePremium 2026-03-31 12144076 bus:FRS102 2025-04-01 2026-03-31 12144076 bus:AuditExempt-NoAccountantsReport 2025-04-01 2026-03-31 12144076 bus:FullAccounts 2025-04-01 2026-03-31 12144076 bus:RegisteredOffice 2025-04-01 2026-03-31 12144076 bus:Director1 2025-04-01 2026-03-31 12144076 bus:Director2 2025-04-01 2026-03-31 12144076 bus:Director3 2025-04-01 2026-03-31 12144076 bus:Director4 2025-04-01 2026-03-31 12144076 bus:OrdinaryShareClass1 2025-04-01 2026-03-31 12144076 bus:EntityHasNeverTraded 2025-04-01 2026-03-31 12144076 bus:PrivateLimitedCompanyLtd 2025-04-01 2026-03-31 12144076 1 2025-04-01 2026-03-31 12144076 countries:EnglandWales 2025-04-01 2026-03-31 12144076 core:CostValuation 2025-03-31 12144076 2024-04-01 2025-03-31 12144076 2025-03-31 12144076 bus:OrdinaryShareClass1 2025-03-31 12144076 core:ShareCapital 2025-03-31 12144076 core:SharePremium 2025-03-31 iso4217:GBP xbrli:pure xbrli:shares

Registration number: 12144076

Droplet Health Limited
Annual Report and Unaudited Financial Statements
for the Year Ended 31 March 2026

Droplet Health Limited

Profit and Loss Account for the Year Ended 31 March 2026

The company has not traded during the year. During this year, the company received no income and incurred no expenditure and therefore made neither profit nor loss.

Droplet Health Limited

(Registration number: 12144076)
Balance Sheet as at 31 March 2026

| Note | 2026 £ | 2025 £
Fixed assets |  |  |
Investments | 3 | 1,680,100 | 1,680,100
Capital and reserves |  |  |
Called up share capital | 4 | 7,586 | 7,586
Share premium reserve |  | 1,672,514 | 1,672,514
Shareholders' funds |  | 1,680,100 | 1,680,100

For the financial year ending 31 March 2026 the company was entitled to exemption from audit under section 480 of the Companies Act 2006 relating to dormant companies.

Directors' responsibilities:

• | The members have not required the company to obtain an audit of its accounts for the year in question in accordance with section 476; and
• | The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

Directors' responsibilities:

• | The members have not required the company to obtain an audit of its accounts for the year in question in accordance with section 476; and
• | The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These financial statements have been prepared and delivered in accordance with the special provisions relating to companies subject to the small companies regime within Part 15 of the Companies Act 2006.

Approved and authorised by the Board on 1 June 2026 and signed on its behalf by:

......................................... Mr Terence Anthony Bloom Director

Droplet Health Limited

Notes to the Unaudited Financial Statements for the Year Ended 31 March 2026

1 | General information

The company is a private company limited by share capital, incorporated in England and Wales.

The address of its registered office is:
Flat 5 Palazzo House
43 Beech Hill
Barnet
EN4 0JW
England

These financial statements were authorised for issue by the Board on 1 June 2026.

2 | Accounting policies

Summary of significant accounting policies and key accounting estimates

The principal accounting policies applied in the preparation of these financial statements are set out below. These policies have been consistently applied to all the years presented, unless otherwise stated.

Statement of compliance

These financial statements have been prepared in accordance with Financial Reporting Standard 102 Section 1A smaller entities - 'The Financial Reporting Standard applicable in the United Kingdom and Republic of Ireland' and the Companies Act 2006 (as applicable to companies subject to the small companies' regime).

Basis of preparation

These financial statements have been prepared using the historical cost convention except that as disclosed in the accounting policies certain items are shown at fair value.

Investments

Investments in equity shares which are publicly traded or where the fair value can be measured reliably are initially measured at fair value, with changes in fair value recognised in profit or loss. Investments in equity shares which are not publicly traded and where fair value cannot be measured reliably are measured at cost less impairment.
Interest income on debt securities, where applicable, is recognised in income using the effective interest method. Dividends on equity securities are recognised in income when receivable.

Share capital

Ordinary shares are classified as equity. Equity instruments are measured at the fair value of the cash or other resources received or receivable, net of the direct costs of issuing the equity instruments. If payment is deferred and the time value of money is material, the initial measurement is on a present value basis.

3 | Investments

| 2026 £ | 2025 £
Investments in subsidiaries | 1,680,100 | 1,680,100

Droplet Health Limited

Notes to the Unaudited Financial Statements for the Year Ended 31 March 2026

Subsidiaries | £
Cost or valuation
At 1 April 2025 | 1,680,100
Provision
Carrying amount
At 31 March 2026 | 1,680,100
At 31 March 2025 | 1,680,100

4 | Share capital

Allotted, called up and fully paid shares

| 2026 | 2025
| No. | £ | No. | £
Share Capital of £1 each | 7,586 | 7,586 | 7,586 | 7,586

5 |

In the opinion of the Directors, there is no ultimate controlling party.

6 | Staff numbers

The average number of persons employed by the company (including directors) during the year, was 0 (2025 - 0).